Novartis
Report Details
ESG Index: Innovation
ESG Index: Innovation
Clinical trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a
particular disease or condition. These studies ensure that an investigative medicine is
effective and safe, and rely entirely on patients and healthy volunteers. For every
Novartis clinical trial our primary responsibility is to protect the safety, well-being and
legal rights of all participants and ensure adherence to the highest ethical standards for
clinical...
Clinical trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a
particular disease or condition. These studies ensure that an investigative medicine is
effective and safe, and rely entirely on patients and healthy volunteers. For every
Novartis clinical trial our primary responsibility is to protect the safety, well-being and
legal rights of all participants and ensure adherence to the highest ethical standards for
clinical...
Report Type
Comprehensive Sustainability Report
Language
English
Year
2023
Format
217.97 MB - PDF
Report Standards:
GRI
ISSB
UN SDG
Similar Reports
(Based on specified tags) Industry / Geography
Report Type
|
2024
Sustainable Living Plan 2025
Our commitment to sustainable business practices and positive social impact across the value chain.
Report Type
|
2025
Sustainable Living Plan 2025
Our commitment to sustainable business practices and positive social impact across the value chain.
Report Type
|
2025
Sustainable Living Plan 2025
Our commitment to sustainable business practices and positive social impact across the value chain.